Financials

  • Market Capitalization 22.12 M
  • Employee 19
  • Founded 2015
  • CEO N/A
  • Website www.abvcpharma.com
  • Headquarter Nevada, United States
  • FIGI BBG000Q844Z2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4531
ALLR
Allarity Therapeutics, Inc. - Common stock
1.41 USD+2.17%-0.70%+17.50%-8.44%22.43 M USD
4533
DYAI
Dyadic International, Inc. - Common Stock
0.61 USD-4.69%-14.08%-42.99%-32.97%22.23 M USD
4537
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.58 USD-19.64%+1.65%+7.01%+132.14%21.98 M USD
4546
LGVN
Longeveron Inc. - Class A Common stock
6.72 USD-1.18%+690.59%+1020.00%+1076.26%21.42 M USD

Notizie